Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.

Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massagué J.

J Clin Invest. 2005 Jan;115(1):44-55.

2.

Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.

Capulli M, Angelucci A, Driouch K, Garcia T, Clement-Lacroix P, Martella F, Ventura L, Bologna M, Flamini S, Moreschini O, Lidereau R, Ricevuto E, Muraca M, Teti A, Rucci N.

J Bone Miner Res. 2012 Nov;27(11):2387-98. doi: 10.1002/jbmr.1686.

4.

Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.

Lee YK, So IS, Lee SC, Lee JH, Lee CW, Kim WM, Park MK, Lee ST, Park DY, Shin DY, Park CU, Kim YS.

J Gene Med. 2005 Feb;7(2):145-57.

PMID:
15546163
5.

Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.

Patel JB, Appaiah HN, Burnett RM, Bhat-Nakshatri P, Wang G, Mehta R, Badve S, Thomson MJ, Hammond S, Steeg P, Liu Y, Nakshatri H.

Oncogene. 2011 Mar 17;30(11):1290-301. doi: 10.1038/onc.2010.510. Epub 2010 Nov 8.

PMID:
21057539
6.
7.

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis.

Fong S, Itahana Y, Sumida T, Singh J, Coppe JP, Liu Y, Richards PC, Bennington JL, Lee NM, Debs RJ, Desprez PY.

Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13543-8. Epub 2003 Oct 24.

8.

Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.

Pommier SJ, Quan GG, Christante D, Muller P, Newell AE, Olson SB, Diggs B, Muldoon L, Neuwelt E, Pommier RF.

Ann Surg Oncol. 2010 Feb;17(2):613-23. doi: 10.1245/s10434-009-0730-z. Epub 2009 Oct 17.

PMID:
19838757
9.

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

Breast Cancer Res. 2009;11(1):R1. doi: 10.1186/bcr2215. Epub 2009 Jan 5.

10.

Molecular signature associated with bone marrow micrometastasis in human breast cancer.

Woelfle U, Cloos J, Sauter G, Riethdorf L, Jänicke F, van Diest P, Brakenhoff R, Pantel K.

Cancer Res. 2003 Sep 15;63(18):5679-84.

11.

Identification of brain- and bone-specific breast cancer metastasis genes.

Klein A, Olendrowitz C, Schmutzler R, Hampl J, Schlag PM, Maass N, Arnold N, Wessel R, Ramser J, Meindl A, Scherneck S, Seitz S.

Cancer Lett. 2009 Apr 18;276(2):212-20. doi: 10.1016/j.canlet.2008.11.017. Epub 2008 Dec 27.

PMID:
19114293
12.

Metastatic behavior of human breast carcinomas overexpressing the Bcl-x(L) gene: a role in dormancy and organospecificity.

Rubio N, España L, Fernández Y, Blanco J, Sierra A.

Lab Invest. 2001 May;81(5):725-34.

PMID:
11351044
13.

Expression of a novel factor in human breast cancer cells with metastatic potential.

Ree AH, Tvermyr M, Engebraaten O, Rooman M, Røsok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O.

Cancer Res. 1999 Sep 15;59(18):4675-80.

14.

Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung.

Al-Sahaf O, Wang JH, Browne TJ, Cotter TG, Redmond HP.

Ann Surg. 2010 Dec;252(6):1037-43. doi: 10.1097/SLA.0b013e3181efc635.

PMID:
21107114
15.

CXCR4 regulates growth of both primary and metastatic breast cancer.

Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, Luker GD.

Cancer Res. 2004 Dec 1;64(23):8604-12.

16.

Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.

Eckhardt BL, Parker BS, van Laar RK, Restall CM, Natoli AL, Tavaria MD, Stanley KL, Sloan EK, Moseley JM, Anderson RL.

Mol Cancer Res. 2005 Jan;3(1):1-13.

17.

Gene expression patterns associated with p53 status in breast cancer.

Troester MA, Herschkowitz JI, Oh DS, He X, Hoadley KA, Barbier CS, Perou CM.

BMC Cancer. 2006 Dec 6;6:276.

18.

Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.

Liu S, Goldstein RH, Scepansky EM, Rosenblatt M.

Cancer Res. 2009 Nov 15;69(22):8742-51. doi: 10.1158/0008-5472.CAN-09-1541. Epub 2009 Nov 3.

19.

Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.

Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C, Ning L, Fang Z, Wang Y, Zhang L, Cheng J, Zhang W, Hao X.

Breast Cancer Res Treat. 2007 Jul;103(3):319-29. Epub 2006 Nov 23. Erratum in: Breast Cancer Res Treat. 2007 May;103(1):125-7.

PMID:
17123152
20.

Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.

Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW, Suva LJ.

Cancer Res. 2002 Oct 1;62(19):5571-9.

Supplemental Content

Support Center